A61P 19 - Drugs for skeletal disorders

Patents for A61P 19 - Drugs for skeletal disorders (81,981)
10/2006
10/18/2006	CN1847261A Cyclic peptides as g-protein-coupled receptor antagonists
10/18/2006	CN1847229A Novel compounds
10/18/2006	CN1847226A Quinolyl amide derivative and its prepn process and use
10/18/2006	CN1846793A Tissue engineering bone and its construction and application
10/18/2006	CN1846790A Injected tissue engineering bone and its constrction and application
10/18/2006	CN1846789A Injected bone repairing material and its prepn and application
10/18/2006	CN1846770A Ointment for treating rheumatism, wound pain and swelling boil
10/18/2006	CN1846767A Chinese medicine bolus for treating protrusion of lumbar intervertebral disc
10/18/2006	CN1846756A Amber bolus
10/18/2006	CN1846753A Medicine composition for treating hyperuricemia
10/18/2006	CN1846741A Superfine Chinese medicine powder prepn for treating rheumatism and its prepn
10/18/2006	CN1846719A Rheumatism treating medicine and its prepn process
10/18/2006	CN1846718A Methods for the production of purified recombinant human uteroglobin for the treatment of inflammatory and fibrotic conditions
10/18/2006	CN1846671A Oral solution containing alfacalcidol
10/18/2006	CN1280288C Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1)
10/18/2006	CN1280275C Pyridione derivatives for tretment of atherosclerosis
10/18/2006	CN1280267C Sulfonylaminocarboxylic acids
10/18/2006	CN1279981C 5-CNAC as oral delivery agent for parathyroid hormone fragments
10/18/2006	CN1279975C Inducer of blood vessel neogenesis
10/18/2006	CN1279973C Injected gel type bone repairing biological active material and its preparing method
10/18/2006	CN1279957C Medicine for treating rheumatoid anthritis and its preparation method
10/18/2006	CN1279948C Medicine for treating arthritis and atrophic arthritis
10/18/2006	CN1279947C Traumatic injury treating medicine
10/18/2006	CN1279944C Medicine for treating cardiocerebral vascular system disease and blood supply deficiency, medicine preparing method and preparation
10/18/2006	CN1279902C Apoptosis inducing adamantyl derivatives and their usage as anti-cancer agents
10/18/2006	CN1279897C Freeze dry preparation containing diclofenac salt and lidocaine and its preparation method
10/18/2006	CN1279895C Ground substance of plaster of Chinese traditional medicine and plaster for external application prepared from the substance
10/17/2006	US7122665 Heterocyclic compounds
10/17/2006	US7122635 Method and composition for angiogenesis inhibition
10/17/2006	US7122572 For use in Hydrogen Bonding Liquid Chromatography, environmental remediation by removal of undesired ions or neutral molecules, removal of phosphate for kidney dialysis, drug delivery, separation
10/17/2006	US7122565 Thiadiazoles and oxadiazoles and their use as phosphodiesterase-7 inhibitors
10/17/2006	US7122556 Phenylalanine enamide derivatives
10/17/2006	US7122554 Sexual disorders therapy; hypotensive agents; chronic obstructive pulmonary disease; congestive heart failure; asthma; antiallergens
10/17/2006	US7122552 Antiallergens; autoimmune diseases; antiproliferative agents; controlling signal transduction
10/17/2006	US7122551 Metalloproteinase inhibitor compounds
10/17/2006	US7122550 Protein kinase inhibitors
10/17/2006	US7122547 Anthranilic acid amides and the use thereof as medicaments
10/17/2006	US7122544 Anilinopyrimidine derivatives as IKK inhibitors and compositions and methods related thereto
10/17/2006	US7122543 Substituted benzoic acid derivatives having NF-κB inhibiting action
10/17/2006	US7122530 24-hydroxyvitamin D, analogs and uses thereof
10/17/2006	US7122517 Crystallized structure of type IV collagen NC1 domain hexamer
10/17/2006	US7122351 Dimerized PDGF-D and materials and methods for producing it
10/17/2006	US7122344 Production of recombinant human uteroglobin (rhUG) for use as a therapeutic in the treatment of inflammation and fibrotic diseases. The invention provides processes, including bacterial expression and protein purification and scaled
10/17/2006	US7122337 Method for determining calciotropic activity of a preparation of Padina pavonic algae
10/17/2006	US7122336 Therapeutic and diagnostic methods for ulcerative colitis and associated disorders
10/17/2006	US7122214 Containing over 30 percent of total flavonoids; the naringin contained in the flavonoids is more than 30 percent
10/17/2006	US7122183 Methods for treating autoimmune and chronic inflammatory conditions using antagonists of CD30 or CD30L
10/12/2006	WO2006107059A1 Medicine for renal perfusion disorder
10/12/2006	WO2006106959A1 Anti-cd-20 monoclonal antibody
10/12/2006	WO2006106914A1 Novel cyclic compound having pyrimidinylalkylthio group
10/12/2006	WO2006106599A1 Pharmaceutical for preventing and/or treating disease caused by abnormal enhancement of extracellular domain shedding
10/12/2006	WO2006105979A1 Sulfonylpyrroles as histone deacetylase inhibitors
10/12/2006	WO2006105615A1 Buccal delivery system
10/12/2006	WO2006047516A3 Compounds and compositions as inhibitors of cannabinoid receptor 1 activity
10/12/2006	US20060229470 Calcium receptor-active molecules
10/12/2006	US20060229363 Substituted Heteroaryl- and Phenylsulfamoyl Compounds
10/12/2006	US20060229333 Quinoline and isoquinoline derivatives, a process for their production and their use as inflammation inhibitors
10/12/2006	US20060229315 3-Substituted Quinoline-4-Carboxamide Derivatives as NK-3 and NK-2 Receptor Antagonists
10/12/2006	US20060229313 Arylpiperazines and arylpiperidines and their use as metalloproteinase inhibiting agents
10/12/2006	US20060229301 To treat inflammatory diseases, immune diseases like autoimmune diseases or allergic diseases, or HIV infection; chemokine receptor antagonists; safe and low-toxic; 1-butyl-3-isobutyl-1,3,8-triazaspiro[4.5]decane-2,4-dione
10/12/2006	US20060229296 1-[4-(2-Azepan-1-yl-ethoxy)-benzyl-2-(4-hydroxy-phenyl])-3-methyl-1H-indol-5-ol, or salts for treating bone loss
10/12/2006	US20060229239 Novel curcuminoid-factor VIIa constructs as suppressors of tumor growth and angiogenesis
10/12/2006	US20060228752 Genetic polymorphisms in the preprotachykinin gene
10/12/2006	US20060228392 capable of enhancing the formation of osseous tissue in the animal in which it is implanted comprising a biocompatible matrix and a NELL-1 protein in an amount effective for stimulating a progenitor cell such that it is activated to differentiate into an osteoblast
10/12/2006	US20060228354 Modified ADAMTS4 molecules and method of use thereof
10/12/2006	US20060228345 Osteogenesis promoter
10/12/2006	US20060228337 Use of bacilli bacteria in order to produce a composition for the prevention of vertebral compression syndrome in salmonids
10/12/2006	US20060225610 Edible phosphoprotein film
10/12/2006	DE102005016138A1 Preparation of a natural remedy, useful to cure e.g. bone rheumatism, comprises e.g. lavendulae ethers and eucalyptus ether in the form of herbal oil that is supplemented with sheabutter and beeswax in the form of herbal balm
10/12/2006	CA2603649A1 Buccal delivery system
10/12/2006	CA2603398A1 Sulfonylpyrroles as histone deacetylase inhibitors
10/11/2006	EP1710307A2 RNA interference mediated inhibition of gene expression using short interfering nucleic acid (siNA)
10/11/2006	EP1710257A1 Hyaluronic acid derivative and drug containing the same
10/11/2006	EP1710242A1 Substituted 2-(2,6-Dioxo-3-Fluoropiperidine-3-YL)-Isoindolines and their use to reduce TNF-alpha levels
10/11/2006	EP1709968A1 P2x receptor inhibitor
10/11/2006	EP1709965A2 Methods of treating cytokine mediate diseases
10/11/2006	EP1709173A2 Methods for inducing differentiation of undifferentiated mammalian cells into osteoblasts
10/11/2006	EP1709171A2 Cloning and characterization of 5' flanking regions of a human aggrecanase-1 gene
10/11/2006	EP1709079A2 Compositions and methods for treating t-cell mediated autoimmune diseases
10/11/2006	EP1709049A1 Bicyclic imidazole compounds, the production thereof and their use as medicaments
10/11/2006	EP1216232B1 Heterocyclic compounds and methods for modulating cxcr3 function
10/11/2006	EP1140149B1 Use of human growth hormone to increase the number of circulating cd34+ cells, intended for reconstitution of the hematopoietic and immune systems following myeloablative or antiblastic therapies, by transplantation, re-infusion or engraftment
10/11/2006	EP1107959B1 Quinazoline derivatives as medicaments
10/11/2006	EP0944619B1 Novel integrin receptor antagonists
10/11/2006	CN1844391A Nucleotide sequence for human morphogenetic protein 9 recombinant proteins and production method and use thereof
10/11/2006	CN1844121A Antipyretic analgesic and anti-arthritis nonsteroidal compound and its pharmaceutical compositions
10/11/2006	CN1843502A Active bone peptide for treating and preventing osteoporosis and its preparing method
10/11/2006	CN1843501A Muscles and bones pain-stopping plaster and preparation method thereof
10/11/2006	CN1843483A Compound fleece-flower root granula for gout
10/11/2006	CN1843468A Method for preparing kidney-strengthening fatigue-relieving liquor containing micron pine pollen, deer bone, king solomonseal rhizome powder etc.
10/11/2006	CN1843467A Method for preparing kidney-strengthening fatigue-relieving boil-free oral liquid containing micron pine pollen, deer bone, king solomonseal rhizome powder etc.
10/11/2006	CN1843465A Method for preparing kidney-strengthening fatigue-relieving tablet containing micron pine pollen, deer bone, king solomonseal rhizome powder etc.
10/11/2006	CN1843463A Medicine for treating barrenness, irregular menses, painful menstruation, endocrine dyscrasia and osteoporosis
10/11/2006	CN1843462A Medicine for treating necrosis of femoral head
10/11/2006	CN1843444A Medicine for treating cervical vertebra disease, lumbar intervertebral disk protrusion, bone fracture and crush fracture
10/11/2006	CN1843441A Rheumatism-eliminating collaterals-dredging externally applied plaster
10/11/2006	CN1843420A General saponin extract of Anemone flaccida Fr. Schmidt
10/11/2006	CN1843393A Use of pharmaceutical composition containing aceglutamide and safflower
10/11/2006	CN1843339A Use of resveratrol in treating rheumatoid arthritis and non-inflammatory disease
10/11/2006	CN1843333A Sodium hyaluronate carulon fat emulsion formulation and its uses

1 ... 389 390 391 392 393 394 395 396 397 398 399 400 401 402 403 404 405 406 407 408 409 ... 820